DOES AGING AGGRAVATE PARKINSONIAN DISABILITY

被引:49
作者
BLIN, J
DUBOIS, B
BONNET, AM
VIDAILHET, M
BRANDABUR, M
AGID, Y
机构
[1] HOP LA PITIE SALPETRIERE,INSERM,U289,47 BD HOP,F-75651 PARIS 13,FRANCE
[2] HOP LA PITIE SALPETRIERE,NEUROL & NEUROPSYCHOL SERV,F-75651 PARIS 13,FRANCE
关键词
D O I
10.1136/jnnp.54.9.780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The influence of age of onset of Parkinson's disease on the severity and the pattern of motor symptoms was investigated by comparing the motor scores with and without levodopa therapy in two groups of patients divided according to age of onset (early < 50, late > 60 years) and matched for disease duration (n = 69 in each group, Study I). The baseline score, that is, the motor disability of patients when off levodopa, was similar in the early- and late- onset groups. In contrast, the residual motor score, assessed when the effect of levodopa treatment was maximum and stable, was significantly higher in the late onset group. When the two groups of patients were matched, in addition, for their residual motor score (n = 54 in each group, Study II), no difference was observed between the early and late onset groups, except for gait disorder which was more severe in older patients. These results suggest that age of onset mainly affects the response to levodopa therapy, because it may increase the prevalence of non-dopaminergic lesions of the brain, including those responsible for gait disorders.
引用
收藏
页码:780 / 782
页数:3
相关论文
共 10 条
  • [1] AGID Y, 1990, ADV NEUROLOGY, V53
  • [2] DOES LONG-TERM AGGRAVATION OF PARKINSONS-DISEASE RESULT FROM NONDOPAMINERGIC LESIONS
    BONNET, AM
    LORIA, Y
    SAINTHILAIRE, MH
    LHERMITTE, F
    AGID, Y
    [J]. NEUROLOGY, 1987, 37 (09) : 1539 - 1542
  • [3] CEDARBAUM JM, 1986, ADV NEUROL, V45, P469
  • [4] EFFECT OF AGE AT ONSET ON PROGRESSION AND MORTALITY IN PARKINSONS-DISEASE
    DIAMOND, SG
    MARKHAM, CH
    HOEHN, MM
    MCDOWELL, FH
    MUENTER, MD
    [J]. NEUROLOGY, 1989, 39 (09) : 1187 - 1190
  • [5] AGE-INDUCED COGNITIVE DISTURBANCES IN PARKINSONS-DISEASE
    DUBOIS, B
    PILLON, B
    STERNIC, N
    LHERMITTE, F
    AGID, Y
    [J]. NEUROLOGY, 1990, 40 (01) : 38 - 41
  • [6] ESTEGUY M, 1985, REV NEUROL, V141, P413
  • [7] GERSTENBRAND F, 1986, J NEURAL TRANSM S, V22, P119
  • [8] THE EFFECT OF AGE OF DISEASE ONSET ON NEUROPSYCHOLOGICAL PERFORMANCE IN PARKINSONS-DISEASE
    HIETANEN, M
    TERAVAINEN, H
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (02) : 244 - 249
  • [9] ONSET AND END-OF-DOSE LEVODOPA-INDUCED DYSKINESIAS - POSSIBLE TREATMENT BY INCREASING DAILY DOSES OF LEVODOPA
    LHERMITTE, F
    AGID, Y
    SIGNORET, JL
    [J]. ARCHIVES OF NEUROLOGY, 1978, 35 (05) : 261 - 263
  • [10] DEMENTIA IN PARKINSON DISEASE
    LIEBERMAN, A
    DZIATOLOWSKI, M
    KUPERSMITH, M
    SERBY, M
    GOODGOLD, A
    KOREIN, J
    GOLDSTEIN, M
    [J]. ANNALS OF NEUROLOGY, 1979, 6 (04) : 355 - 359